[Change in the nonspecific reactivity of patients with neoplasia of the uterus and ovaries during treatment].
D015068:17-Ketosteroids / Q000652:urine*; D000328:Adult; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007889:Leiomyoma / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy* / Q000652:urine; D008875:Middle Aged; D010048:Ovarian Cysts / Q000097:blood / Q000652:urine; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy* / Q000652:urine; D011414:Properdin / Q000097:blood; D011878:Radiotherapy; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy* / Q000652:urine
D015068:17-Ketosteroids; D011414:Properdin; D003165:Complement System Proteins
Zmina nespetsifichnoi reaktivnosti khvorikh z novoutvorenniami matki i pridatkiv u protsesi likuvannia.